Showing results (1-10 of 161) with videos related to
Sort By:
Pageof 17
Clinical Pharmacology and Therapeutics|October 23, 1997
Fluvoxamine inhibits the CYP2C19-catalyzed bioactivation of chloroguanideU Jeppesen, B B Rasmussen, K BrøsenTherapeutic Drug Monitoring|February 1, 1997
Griseofulvin and fluvoxamine interactions with the metabolism of theophyllineB B Rasmussen, U Jeppesen, D Gaist, et al.Pharmacogenetics|April 20, 1999
The stereoselective metabolism of fluoxetine in poor and extensive metabolizers of sparteineL Fjordside, U Jeppesen, C B Eap, et al.European Journal of Clinical Pharmacology|January 1, 1996
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetineU Jeppesen, L F Gram, K Vistisen, et al.Clinical Pharmacokinetics|January 1, 1995
Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2K BrøsenTherapeutic Drug Monitoring|August 1, 1996
Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatryK BrøsenBritish Journal of Clinical Pharmacology|October 1, 1986
Sparteine oxidation polymorphism in Greenlanders living in DenmarkK BrøsenInternational Clinical Psychopharmacology|November 17, 1998
Differences in interactions of SSRIsK BrøsenUgeskrift for Laeger|February 4, 1991
[The significance of cytochrome P450 gene superfamily for the clinical pharmacokinetics of drugs]K BrøsenPageof 17